Mesenchymal Stem Cells (MSC) for Ovarian Cancer

Summary

The goal of this clinical research study is to find the highest tolerable dose of human mesenchymal stem cells with interferon beta (MSC-INFb) that can be given to patients with ovarian cancer and to test the safety of the MSC-INFb. This is an investigational study. MSC-INFb infusions for ovarian cancer is investigational. Up to 21 patients will take part in this study. All will be enrolled at MD Anderson.

Timeline

Start

2016-05-16

Primary completion

2019-06-13

Completion

2019-06-13

Drugs

Indications